Purdue’s bankruptcy plan has been approved. Where is the money?



NOTTwo months ago, a U.S. bankruptcy court judge approved a controversial Purdue Pharma plan that would channel billions of dollars to pay for the damage caused by the opioid painkiller OxyContin.

Basically, the deal called for some members of the Sackler family – who controlled Purdue – to pay more than $ 4.3 billion over nearly a decade to compensate individuals, state and local governments and tribal communities across the country. cost of the opioid crisis. The deal followed some 3,000 lawsuits that prompted the company to file for bankruptcy in 2019. But even though the plan was approved, the money hasn’t started to flow and it’s unclear when that will. will produce.

Unlock this article by subscribing to STAT + and enjoy your first 30 days free!


What is that?

STAT + is STAT’s premium subscription service for in-depth coverage and analysis of biotechnology, pharmaceuticals, policy and life sciences. Our award-winning team covers news from Wall Street, political developments in Washington, early scientific breakthroughs and clinical trial results, as well as healthcare disruptions in Silicon Valley and beyond.

What is included?

  • Daily reporting and analysis
  • Industry’s most comprehensive coverage from a powerful team of journalists
  • Newsletters reserved for subscribers
  • Daily newsletters to keep you informed of the most important industry news of the day
  • STAT + conversations
  • Weekly opportunities to engage with our journalists and leading industry experts in live video chats
  • Exclusive industry events
  • Premium access to subscriber-only networking events nationwide
  • The best reporters in the industry
  • The most reliable and most connected newsroom in the healthcare industry
  • And much more
  • Exclusive interviews with industry leaders, profiles and premium tools, like our CRISPR Trackr.



About Author

Leave A Reply